IDEAYA Biosciences (IDYA) Amortizatization of Intangibles (2018 - 2026)
IDEAYA Biosciences (IDYA) reported Amortizatization of Intangibles of $1.2 million for Q1 2026, down 67.95% on a YoY basis from $3.8 million in Q1 2025, and down 20.54% sequentially from $1.5 million in Q4 2025.
IDEAYA Biosciences (IDYA) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 9 years of Amortizatization of Intangibles data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 67.95% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $7.4 million (down 64.2% YoY), and the FY2025 full-year result was $10.0 million, down 57.06% from the prior year.
- Amortizatization of Intangibles declined to $1.2 million in Q1 2026, from $1.5 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $6.6 million in Q2 2024 to a low of -$349000.0 in Q1 2022.
- A 5-year average of $2.7 million and a median of $2.6 million in 2023 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles jumped 4046.51% in 2023 and sank 69.0% in 2025, its largest moves.
- Tracing IDYA's Amortizatization of Intangibles over 5 years: stood at $1.1 million in 2022, then surged by 243.92% to $3.9 million in 2023, then grew by 26.83% to $4.9 million in 2024, then tumbled by 69.0% to $1.5 million in 2025, then declined by 20.54% to $1.2 million in 2026.
- Business Quant data shows IDYA's Amortizatization of Intangibles at $1.2 million in Q1 2026, $1.5 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | IDEAYA Biosciences | 3.26 Bn | 2.59 Bn | - | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.21 Mn |
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 2.69 Mn |
| Jun 30, 2025 | 2.69 Mn |
| Mar 31, 2025 | 3.78 Mn |
| Mar 31, 2025 | 3.78 Mn |
| Dec 31, 2024 | 4.92 Mn |
| Dec 31, 2024 | 4.92 Mn |
| Sep 30, 2024 | 5.36 Mn |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 6.64 Mn |
| Jun 30, 2024 | 6.64 Mn |
| Mar 31, 2024 | 6.31 Mn |
| Mar 31, 2024 | 6.31 Mn |
| Dec 31, 2023 | 3.88 Mn |
| Dec 31, 2023 | 3.88 Mn |